Interestingly, Kp-10 immunostaining intensity was higher in NAT BPH/5 GE and DE when compared to the same tissue in NAT C57 (Figure 3C,G–I and M–O; p < 0.001), whereas no difference in staining intensity was noted in the IIS LE of NAT BPH/5 and C57 females (Figure 3C,J–L; p > 0.05). The gene discussed is BRD2; the disease is benign prostatic hyperplasia.